GlassScriptPhysician profile
Sharif Denden
NPI 1578093795
$10,333.04
in general payments reported to CMS, 2019-2025
26 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $2,870 · 2021: $1,536 · 2022: $731 · 2023: $2,670 · 2024: $1,036 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,300 · Travel and Lodging: $1,162 · Gift: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,299.95 |
| Travel and Lodging | $1,162.30 |
| Gift | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $2,176.41 | 2023-2024 | |
| Medwest Associates | $2,139.27 | 2020-2021 | |
| Amniox Medical, INC. | $1,701.95 | 2020 | |
| Stryker Corporation | $1,120.21 | 2020-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Ortholoc 3di |
| Acera Surgical, INC. | $628.93 | 2019-2024 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $590.90 | 2020-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Wright Medical Technology, INC. | $412.68 | 2019-2020 | |
| Orthofix Medical, INC. | $216.72 | 2019-2025 | Physio-Stim, Tl-Hex Truelok Hexapod System, Galaxy Fixation System |
| Zimmer Biomet Holdings, INC. | $193.93 | 2019 | |
| Organogenesis INC. | $179.49 | 2019-2022 | |
| Melinta Therapeutics, LLC | $147.44 | 2020-2022 | |
| Extremity Medical | $132.74 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Depuy Synthes Sales INC. | $88.01 | 2022-2025 | Va-Lcp |
| Kerecis Limited | $83.18 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $69.10 | 2023 | Acumed, Osteomed |
| Abbott Laboratories | $61.92 | 2023-2024 | Proclaim |
| Paragon 28, INC. | $61.45 | 2022-2025 | Mtp, Phantom Fibula Nail |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.19 | 2023-2025 | Jublia |
| Lightbody Medical Technologies INC | $35.60 | 2025 | |
| Treace Medical Concepts, INC. | $27.19 | 2025 | |
| Solventum Corporation | $23.29 | 2025 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $18.94 | 2025 | Nuzyra |
| Normatec Industries, LP | $17.67 | 2020 | |
| Horizon Therapeutics Plc | $14.22 | 2022 | |
| Next Science LLC | $12.98 | 2023 | Surgx, Blastx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharif Denden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.